We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$117B
AUM Growth
-$6.8B
(-5.5%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-1.67%
Top 10 Holdings %
Top 10 Hldgs %
30.2%
Holding
4,248
New
63
Increased
1,950
Reduced
1,821
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$162M |
| 2 |
Vertiv
VRT
|
+$52.4M |
| 3 |
Palo Alto Networks
PANW
|
+$34.3M |
| 4 |
Waters Corp
WAT
|
+$21.5M |
| 5 |
Pinnacle Financial Partners Inc
PNFP
|
+$20.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 3000 ETF
IWV
|
+$607M |
| 2 |
Apple
AAPL
|
+$186M |
| 3 |
Microsoft
MSFT
|
+$139M |
| 4 |
Meta Platforms (Facebook)
META
|
+$89.6M |
| 5 |
NVIDIA
NVDA
|
+$74.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.6% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 10.32% |
| 4 | Industrials | 10.12% |
| 5 | Healthcare | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIQ
2376
NIQ Global Intelligence PLC
NIQ
$3.34B
| $575K | ﹤0.01% |
50,540
+11,831
| +31% | +$160K |
|
2377
Cars.com
CARS
$662M
| $573K | ﹤0.01% |
70,575
-86,642
| -55% | -$886K |
|
2378
Sana Biotechnology
SANA
$910M
| $572K | ﹤0.01% |
198,696
+9,284
| +5% | +$36.6K |
|
2379
AngioDynamics
ANGO
$570M
| $572K | ﹤0.01% |
50,294
-2,316
| -4% | -$25.1K |
|
2380
International Money Express
IMXI
$387M
| $571K | ﹤0.01% |
36,130
-808
| -2% | -$12.6K |
|
2381
MiMedx Group
MDXG
$649M
| $570K | ﹤0.01% |
144,243
-7,598
| -5% | -$38.3K |
|
|
JBIO
2382
Jade Biosciences
JBIO
$1.24B
| $570K | ﹤0.01% |
40,551
-9,502
| -19% | -$138K |
|
2383
Civista Bancshares
CIVB
$594M
| $570K | ﹤0.01% |
24,994
-73
| -0.3% | -$1.69K |
|
2384
Strive Inc
ASST
$1,000M
| $569K | ﹤0.01% |
+56,787
| New | +$707K |
|
2385
Bloomin' Brands
BLMN
$729M
| $568K | ﹤0.01% |
105,245
-139,084
| -57% | -$890K |
|
2386
Red River Bancshares
RRBI
$655M
| $568K | ﹤0.01% |
6,278
-118
| -2% | -$9.98K |
|
|
PUB
2387
DELISTED
PUBLICIS SA ADS (1 ADS = 1C0M)
PUB
| $567K | ﹤0.01% |
27,386
+691
| +3% | +$14.3K |
|
2388
Opko Health
OPK
$929M
| $567K | ﹤0.01% |
497,240
-14,239
| -3% | -$17.5K |
|
2389
Aquestive Therapeutics
AQST
$468M
| $567K | ﹤0.01% |
136,539
+3,000
| +2% | +$12.2K |
|
|
DRUG
2390
Bright Minds Biosciences
DRUG
$716M
| $566K | ﹤0.01% |
7,762
+1,826
| +31% | +$147K |
|
2391
Emergent Biosolutions
EBS
$383M
| $566K | ﹤0.01% |
68,218
-447
| -0.7% | -$4.63K |
|
2392
Ardagh Metal Packaging
AMBP
$2.89B
| $565K | ﹤0.01% |
139,617
+293
| +0.2% | +$1.3K |
|
2393
Grindr
GRND
$2.75B
| $565K | ﹤0.01% |
46,766
+729
| +2% | +$8.59K |
|
|
CBLL
2394
CeriBell Inc
CBLL
$675M
| $564K | ﹤0.01% |
30,790
+330
| +1% | +$6.63K |
|
2395
EverQuote
EVER
$931M
| $564K | ﹤0.01% |
36,565
-360
| -1% | -$6.81K |
|
2396
Varex Imaging
VREX
$459M
| $562K | ﹤0.01% |
52,996
-740
| -1% | -$9.45K |
|
2397
Kura Sushi USA
KRUS
$567M
| $561K | ﹤0.01% |
8,033
-9
| -0.1% | -$604 |
|
2398
Build-A-Bear
BBW
$428M
| $560K | ﹤0.01% |
14,946
-598
| -4% | -$31.5K |
|
|
CVGW
2399
DELISTED
Calavo Growers
CVGW
| $558K | ﹤0.01% |
21,655
-1,188
| -5% | -$29.8K |
|
|
RZLV
2400
Rezolve AI
RZLV
$905M
| $556K | ﹤0.01% |
217,171
+31,568
| +17% | +$89K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2026 Portfolio in Review
As of Q1 2026, RhumbLine Advisers held 4,248 positions worth $117B, down 5.5% from $124B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.9%. RhumbLine Advisers opened 63 new positions and exited 101, leaving the 4,248-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q1 2026 buy was Versant Media Group: 361,319 shares worth $13.4M.
- RhumbLine Advisers added most to Marsh in Q1 2026, an estimated $162M increase.
- RhumbLine Advisers's biggest Q1 2026 reduction was iShares Russell 3000 ETF, cutting an estimated $607M.
- RhumbLine Advisers fully exited Everpure Inc in Q1 2026, selling an estimated $58.7M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $117B portfolio in Q1 2026.
- RhumbLine Advisers opened 63 new positions and closed 101 in Q1 2026.
- RhumbLine Advisers's portfolio value fell 5.5% quarter-over-quarter to $117B.
Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.